RETHINKDEPRESSION

Serial Number 98832290
692

Registration Progress

Application Filed
Nov 1, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

RETHINKDEPRESSION

Basic Information

Serial Number
98832290
Filing Date
November 1, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
692
Status Date
Apr 10, 2025
Application
Pending
Classes
005 041 042 044

Rights Holder

H. Lundbeck A/S

99
Address
Ottiliavej 9
Valby 2500
DK

Ownership History

H. Lundbeck A/S

Original Applicant
99
Valby DK

Legal Representation

Attorney
Maren C. Perry

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

12 events
Date Code Type Description Documents
Apr 10, 2025 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Apr 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 4, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 5, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 5, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 5, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 18, 2024 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Sanitary preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine; diagnostic preparations, substances, reagents and agents for medical purposes
Class 041
Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous systems diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online publications in the nature of books, reports, brochures, booklets, magazines, leaflets, journals, teaching and training materials in the fields of science, clinical trials and tests, diagnostics and medicine; arranging and conducting in-person and online educational expert forums in the fields of science, clinical trials and tests, diagnostics and medicine
Class 042
Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing online non-downloadable software for accessing data and information in the fields of research and development, science, clinical studies, trials and tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of disorders, diseases and prevention; scientific and technological services, namely, research and design in the field of central nervous system stimulants, pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases and drugs; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system stimulants, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical research information in the fields of research and development, science, clinical studies, trials and tests
Class 044
Medical services; medical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical consultancy relating to medical and pharmaceutical preparations; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical and therapeutic services relating to the treatment and prevention of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical advice and medical information in the field of diagnostics, medicine, drugs, disorders, diseases, treatment and prevention; medical information service, namely, provision of medical information related to the medical dosage, diagnosis, therapeutic topics, medical administration, treatment and prevention of central nervous system disorders and diseases, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online medical data and analytics designed to provide patients and clients with tailored information, on medical dosage, diagnoses, therapeutic topics and medical administration

Additional Information

Design Mark
The mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
Color Claim
The color(s) red and blue are claimed as a feature of the mark.
Pseudo Mark
RETHINK DEPRESSION

Classification

International Classes
005 041 042 044